Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000483539 | SCV000573795 | pathogenic | not provided | 2017-02-23 | criteria provided, single submitter | clinical testing | The c.9602dupT pathogenic variant in the KMT2D gene causes a frameshift starting with codon Serine 3202, changes this amino acid to a Glutamic acid residue and creates a premature Stop codon at position 13 of the new reading frame, denoted p.Ser3202GlufsX13. This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Although this pathogenic variant has not been previously reported to our knowledge, its presence is consistent with the diagnosis of Kabuki syndrome in this individual. |
Sbielas Lab- |
RCV000578199 | SCV000680057 | pathogenic | Kabuki syndrome 1 | 2017-10-27 | no assertion criteria provided | research | |
University of Washington Center for Mendelian Genomics, |
RCV001034583 | SCV001197963 | likely pathogenic | CHARGE syndrome | no assertion criteria provided | research |